NCT06141889View on ClinicalTrials.gov

Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

January 26, 2024

Study Completion Date

February 2, 2024

Conditions
Healthy Volunteer Study
Interventions
DRUG

Azelaprag

oral, apelin receptor (APJ) agonist

Trial Locations (1)

Unknown

New Zealand Clinical Research, Auckland

Sponsors

Lead Sponsor

BioAge Labs, Inc.
All Listed Sponsors
lead

BioAge Labs, Inc.

INDUSTRY